Genetic Testing in Patients with Non-Small Cell Lung Cancer Before or After Surgery
Studying the genes in a patient's tumor cells may help determine the best treatment for patients with certain genetic changes.
Lung Adenocarcinoma, Lung Large Cell Carcinoma, Resectable Lung Non-Small Cell Carcinoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage IB Lung Squamous Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage II Lung Squamous Cell Carcinoma AJCC v7, Stage IIA Lung Non-Small Cell Carcinoma AJCC v7, Stage IIA Lung Squamous Cell Carcinoma AJCC v7, Stage IIB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIB Lung Squamous Cell Carcinoma AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Squamous Cell Carcinoma AJCC v7, Carcinoma, Carcinoma, Squamous Cell, Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Carcinoma, Large Cell, Gemcitabine, Paclitaxel, Cisplatin, Carboplatin, Pembrolizumab, Nivolumab, Pemetrexed, Albumin-Bound Paclitaxel, Crizotinib, Clinical Observation, Cytology Specimen Collection Procedure, Erlotinib, Gemcitabine Hydrochloride, Pemetrexed Disodium
Lead Scientists at UC Cancer
- Lyudmila A. Bazhenova (ucsd)
Dr. Bazhenova’s clinical practice and research concentrate on lung cancer, particularly as this relates to females and non-smokers. She actively participates in cooperative group trials, and takes an active role in designing and implementing clinical investigations, including phase II studies and correlative science projects with several UCSD investigators.
- David R. Gandara (ucdavis)
Professor, Hematology and Oncology, School of Medicine. Authored (or co-authored) 486 research publications
- Karen G. Chee (ucsf)
- accepting new patients
- Start Date
- National Cancer Institute (NCI)
- Study Type
- Expecting 8300 study participants
- Last Updated